Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
23.18
+0.67 (2.98%)
At close: Oct 15, 2026, 4:00 PM EDT
23.06
-0.12 (-0.52%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Collegium Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $48 | Buy | Maintains | $48 | +107.08% | Oct 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 | Buy | Reiterates | $50 | +115.70% | Oct 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $60 | Buy | Maintains | $60 | +158.84% | Sep 21, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $45 | Buy | Initiates | $45 | +94.13% | Sep 9, 2026 |
| Truist Financial No rating | Truist Financial | Buy Initiates $58 → $49 | Buy | Initiates | $58 → $49 | +111.39% | Sep 9, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $45 → $43 | Hold | Reiterates | $45 → $43 | +85.50% | Aug 7, 2026 |
| Needham | Needham | Buy Maintains $56 → $46 | Buy | Maintains | $56 → $46 | +98.45% | Aug 6, 2026 |